Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07830459) titled 'Caffeine Dose and Duration in Habitual Female Users' on Sept. 15.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: Double (Participant, Investigator).
Primary Sponsor: Birjand University of Medical Sciences
Condition:
Caffeine
Athletic Performance
Resistance Traaining
Intervention:
Dietary Supplement: Caffeine 3 mg/kg
Dietary Supplement: Caffeine 6 mg/kg
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: February 12, 2023
Target Sample Size: 36
Countries of Recruitment:
Iran
To know ...